FDA Investigator: Temar Q. Williams
- Temar Q. Williams first started conducting FDA inspections in 2003, with the last inspection in 2017. Over that time, Temar Q. Williams has conducted 29 inspections at 26 companies across 25 sites.
Get Temar Williams's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Cambrex Profarmaco Milano Srl, Paullo | 2017
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Mutual Pharmaceutical Company, Inc., Philadelphia | 2014
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Albhades Provence, Oraison | 2012
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Gruppo Lepetit Srl, Anagni | 2012
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Bristol Myers Squibb, Anagni | 2012
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Teva Pharmaceuticals USA Inc, Sellersville | 2011
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Shouguang Fukang Pharmaceutical Co., Ltd., Shougang City, Shandong | 2011
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc., Fort Washington | 2010
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Zhejiang Gold Pharma Co., Ltd., ZHEJIANG PROVINCE | 2010
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 Zoetis Suzhou Manufacturing Company Ltd., Suzhou | 2010
Out-of-stock
Temar Q. Williams
Animal Drugs & Feed Form 483
FDA 483 Lannett Company Inc., Philadelphia | 2010
Out-of-stock
Temar Q. Williams
Human Drug Form 483
FDA 483 A & M StabTest GmbH, Bergheim | 2009
Out-of-stock
Temar Q. Williams
Human Drug Form 483
Co-Investigators (22)
- Margaret M. Annes, FDA Investigator
- Thomas E. Friel, FDA Investigator
- James M. Mason, FDA Investigator
- Gayle S. Lawson, FDA Investigator
- Vlada Matusovsky, FDA Investigator
- Denise M. Digiulio, FDA Investigator
- Erika V. Butler, FDA Investigator
- Francis A. Guidry, FDA Investigator
- Joseph L. Despins, FDA Investigator
- Anita R. Michael, FDA Investigator
- Linda M. Hoover, FDA Investigator
- James C. Maclaughlin, FDA Investigator
- Matthew R. Noonan, FDA Investigator
- Sam Pepe, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Mark R. McClain, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Melissa J. Garcia, FDA Investigator
- Gerald B. Seaborn, FDA Investigator
- Annemarie Bodnar, FDA Investigator
- Rochelle L. Cross, FDA Investigator
- Richard E. Needham, FDA Investigator